Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NewAmsterdam Pharma Co N.V (NAMS) Exchange Rate Effect: 2023-2025

Historic Exchange Rate Effect for NewAmsterdam Pharma Co N.V (NAMS) over the last 3 years, with Sep 2025 value amounting to $222,000.

  • NewAmsterdam Pharma Co N.V's Exchange Rate Effect fell 95.11% to $222,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $4.9 million, marking a year-over-year decrease of 23.18%. This contributed to the annual value of -$6.8 million for FY2024, which is 234.64% down from last year.
  • As of Q3 2025, NewAmsterdam Pharma Co N.V's Exchange Rate Effect stood at $222,000, which was down 97.48% from $8.8 million recorded in Q2 2025.
  • NewAmsterdam Pharma Co N.V's Exchange Rate Effect's 5-year high stood at $8.8 million during Q2 2025, with a 5-year trough of -$7.9 million in Q4 2024.
  • For the 3-year period, NewAmsterdam Pharma Co N.V's Exchange Rate Effect averaged around $1.0 million, with its median value being $222,000 (2025).
  • Per our database at Business Quant, NewAmsterdam Pharma Co N.V's Exchange Rate Effect plummeted by 252.05% in 2024 and then soared by 1,070.96% in 2025.
  • NewAmsterdam Pharma Co N.V's Exchange Rate Effect (Quarterly) stood at $5.2 million in 2023, then tumbled by 252.05% to -$7.9 million in 2024, then plummeted by 95.11% to $222,000 in 2025.
  • Its Exchange Rate Effect stands at $222,000 for Q3 2025, versus $8.8 million for Q2 2025 and $3.8 million for Q1 2025.